Market Tracker

08/20 4:25pm ET

Neuralstem Inc (NYSE MKT LLC:CUR)

3.55
Data as of 4:00pm ET
 -0.07 / -1.93%
Today’s Change
1.52
Today|||52-Week Range
4.81
+21.99%
Year-to-Date
A Winning Biotech Strategy
Aug 14 / Investing Channel
 

Today’s Trading

Previous close3.62
Today’s open3.62
Day’s range3.55 - 3.69
Volume365,912
Average volume (3 months)932,582
Market cap$314.3M
Dividend yield--
Data as of 4:00pm ET, 08/20/2014

Growth & Valuation

Earnings growth (last year)-58.82%
Earnings growth (this year)+18.52%
Earnings growth (next 5 years)--
Revenue growth (last year)-73.02%
P/E ratioNM
Price/Sales1,912.11
Price/Book33.49

Competitors

 Today’s
change
Today’s
% change
--Axim Biotechnologies...0.000.00%
RTRXRetrophin Inc+0.07+0.58%
ANIPANI Pharmaceuticals ...-0.58-1.98%
OVASOvaScience Inc-0.37-3.08%
Data as of 3:59pm ET, 08/20/2014

Financials

Next reporting dateNovember 18, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$110.0K
Annual profit (last year)-$19.8M
Net profit margin-18,028.97%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientific Officer
Karl Y. Johe
President, CEO, CFO, Director &
Legal Counsel
I. Richard Garr
Corporate headquarters
Germantown, Maryland

Forecasts